Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Baricitinib may effectively treat nail changes in alopecia areata.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Upadacitinib may effectively treat resistant lichen planopilaris.

Alpinetin helps grow hair by turning on hair stem cells and is safe for use.

The FDA approved a new Pfizer drug for hair loss in teens.

Baricitinib is the most effective treatment for alopecia areata.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.